🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11191763

HIV post-exposure prophylaxis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11185581

Human rotavirus G9P[6] strain and use as a vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11180751

CRISPR enzymes and systems

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11174292

Substitutions-modified prefusion RSV F proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11173201

Methods and compositions for inducing protective immunity against filovirus infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11167025

Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11167012

Peptide inhibition of CCR3-mediated diseases or conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11154574

Tumor infiltrating lymphocytes and methods of therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11147837

Modified cells and methods of therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11147867

Stabilized influenza hemagglutinin stem region trimers and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11136356

Recombinant HIV-1 envelope proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11130785

Prefusion RSV F proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11129835

Methods and compositions for the inhibition of PIN1

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11116830

Bacterial polysaccharide-conjugated carrier proteins and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11110089

Pyridazinones and their use in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11111306

IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11110150

Complexes of IL-15 and IL-15Ralpha and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11110181

Virus-like particle conjugates for diagnosis and treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11111478

Methods of producing T memory stem cell populations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11103572

Thermal inactivation of rotavirus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11098084

Virus-like particles and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11098283

T cells modified to overexpress c-Myb

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11096927

Anti-flavivirus compounds and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11091509

HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted